Reetobrata Basu Selected Research

Melanoma (Melanoma, Malignant)

1/2022	Growth hormone receptor antagonism downregulates ATP-binding cassette transporters contributing to improved drug efficacy against melanoma and hepatocarcinoma in vivo.
12/2020	Growth Hormone Upregulates Mediators of Melanoma Drug Efflux and Epithelial-to-Mesenchymal Transition In Vitro and In Vivo.
9/2019	Growth Hormone Upregulates Melanocyte-Inducing Transcription Factor Expression and Activity via JAK2-STAT5 and SRC Signaling in GH Receptor-Positive Human Melanoma.
3/2017	Targeting growth hormone receptor in human melanoma cells attenuates tumor progression and epithelial mesenchymal transition via suppression of multiple oncogenic pathways.
1/2017	Growth Hormone Receptor Knockdown Sensitizes Human Melanoma Cells to Chemotherapy by Attenuating Expression of ABC Drug Efflux Pumps.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Reetobrata Basu Research Topics

Disease

12	Neoplasms (Cancer) 01/2023 - 01/2017
5	Melanoma (Melanoma, Malignant) 01/2022 - 01/2017
3	Acromegaly 01/2023 - 11/2020
2	Fibrosis (Cirrhosis) 01/2023 - 01/2022
2	Chagas Disease (American Trypanosomiasis) 01/2023 - 01/2022
2	Insulin Resistance 12/2021 - 01/2020
2	Tuberculosis (Tuberculoses) 02/2015 - 01/2014
1	Laron Syndrome (Syndrome, Laron) 01/2023
1	Pain (Aches) 01/2023
1	Infections 01/2023
1	Cognitive Dysfunction 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Growth Disorders 01/2021
1	Body Weight (Weight, Body) 01/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2014

Drug/Important Bio-Agent (IBA)

10	Growth Hormone (Somatotropin)IBA 01/2023 - 03/2017
4	Somatotropin Receptors (Growth Hormone Receptor)IBA 01/2022 - 01/2017
3	Insulin-Like Growth Factor I (IGF-1)IBA 01/2023 - 01/2020
3	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2022 - 01/2017
2	Insulin (Novolin)FDA Link 01/2023 - 01/2020
2	bovine growth hormoneIBA 01/2023 - 11/2020
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2017
2	Adenosine Triphosphate (ATP)IBA 01/2022 - 01/2017
2	Small Interfering RNA (siRNA)IBA 03/2017 - 01/2017
2	Adenosine Triphosphatases (ATPase)IBA 02/2015 - 01/2014
2	DNA GyraseIBA 02/2015 - 01/2014
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2023
1	CollagenIBA 01/2023
1	Extracellular Matrix ProteinsIBA 01/2023
1	Sorafenib (BAY 43-9006)FDA Link 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Human Growth Hormone (Saizen)FDA LinkGeneric 01/2021
1	Insulin-Like PeptidesIBA 12/2020
1	Prolactin Receptors (Prolactin Receptor)IBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 09/2019
1	Carrier Proteins (Binding Protein)IBA 03/2017
1	Messenger RNA (mRNA)IBA 03/2017
1	oridoninIBA 01/2017
1	XenobioticsIBA 01/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2017
1	VemurafenibIBA 01/2017
1	EnzymesIBA 01/2014
1	Moxifloxacin (Avelox)FDA Link 01/2014

Therapy/Procedure

6	Therapeutics 01/2023 - 01/2017
1	Drug Therapy (Chemotherapy) 01/2017